相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
该BioSIM 抗人 PD-1/CD279 抗体 (信迪利 / 信迪利单抗),生物类似药,科研用途 [ CAS: 2072873-06-2]的免疫原请参考该产品的说明书
- 保存条件:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 克隆性:
单克隆
- 适应物种:
Human
- 保质期:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 级别:
科研级别
- 库存:
999
- 供应商:
亚科因(Abbkine)
- 宿主:
Human
- 应用范围:
ELISA, FACS, Functional assay, Research in vivo
- 抗体英文名:
PD-1/CD279
- 抗体名:
PD-1/CD279
- 规格:
5mg
BioSIM 抗人 PD-1/CD279 抗体(信迪利单抗生物类似药,科研级)
英文名称:BioSIM anti-Human PD-1/CD279 Antibody (Sintilimab Biosimilar), Research Grade
产品货号:SIM0031-5mg
产品规格:5mg
产品类型:二抗(科研用途)
供应商:InvivoCrown
CAS号:2072873-06-2
关键特性
- 与信迪利单抗具有相同可变区,适配生物类似药相关基础研究
- 属于人源化IgG4κ单抗,携带S228P突变
- 对人PD-1(CD279)的亲和力高于纳武单抗/帕博利珠单抗
- 可与食蟹猴PD-1发生交叉反应,支持跨物种实验设计
背景与研究应用领域
PD-1(CD279)作为免疫检查点分子,通过与PD-L1结合调节免疫稳态;肿瘤细胞常利用该通路逃避免疫监视。
本产品为信迪利单抗的非治疗性生物类似药,适用于以下研究方向:
- 霍奇金淋巴瘤(HL)
- 非小细胞肺癌(NSCLC)
- 食管癌
适用实验类型
- ELISA:PD-1蛋白的定性/定量检测
- FACS:细胞表面PD-1表达水平分析
- Functional assay:PD-1通路阻断效果评估
- In vivo研究:动物模型(含食蟹猴)的肿瘤免疫实验
保存建议
- 严格避免反复冻融,以防抗体活性下降
- 短期储存(1-2周):4°C避光保存
- 中期储存(最长12个月):-20°C避光保存
- 长期储存:-80°C避光保存
免疫原信息
本产品免疫原细节请参考随附的产品说明书
注意:以上信息可能随着产品优化升级等因素产生变动,具体信息请咨询亚科因公司。

BioSIM Anti-Human PD-1/CD279 Antibody (Sintilimab Biosimilar), Research Grade
Product Name: BioSIM anti-Human PD-1/CD279 Antibody (Sintilimab Biosimilar), Research Grade
Catalog Number: SIM0031-5mg
Size: 5mg
Product Type: Secondary Antibody (For Research Use Only)
Supplier: InvivoCrown
CAS Number: 2072873-06-2
Key Features
- Shares identical variable regions with Sintilimab, suitable for basic research related to biosimilars
- A humanized IgG4κ monoclonal antibody with S228P mutation
- Affinity for human PD-1 (CD279) is higher than Nivolumab/Pembrolizumab
- Shows cross-reactivity with cynomolgus monkey PD-1, supporting cross-species experimental design
Background and Research Applications
PD-1 (CD279) as an immune checkpoint molecule regulates immune homeostasis by binding to PD-L1; tumor cells often utilize this pathway to evade immune surveillance.
This product is a non-therapeutic biosimilar of Sintilimab, suitable for the following research directions:
- Hodgkin's Lymphoma (HL)
- Non-Small Cell Lung Cancer (NSCLC)
- Esophageal Cancer
Suitable Experimental Types
- ELISA: Qualitative/quantitative detection of PD-1 protein
- FACS: Analysis of cell surface PD-1 expression levels
- Functional assay: Evaluation of PD-1 pathway blocking effects
- In vivo studies: Tumor immunity experiments in animal models (including cynomolgus monkeys)
Storage Recommendations
- Strictly avoid repeated freeze-thaw cycles to prevent decreased antibody activity
- Short-term storage (1-2 weeks): Store at 4°C protected from light
- Medium-term storage (up to 12 months): Store at -20°C protected from light
- Long-term storage: Store at -80°C protected from light
Immunogen Information
Please refer to the accompanying product manual for details of the immunogen for this product
Note: The above information may change due to product optimization and upgrades. Please consult InvivoCrown for specific information.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验
技术资料暂无技术资料 索取技术资料






